GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (STU:ET80) » Definitions » Cyclically Adjusted Book per Share

AEterna Zentaris (STU:ET80) Cyclically Adjusted Book per Share : €231.65 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is AEterna Zentaris Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

AEterna Zentaris's adjusted book value per share for the three months ended in Mar. 2024 was €9.829. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €231.65 for the trailing ten years ended in Mar. 2024.

During the past 12 months, AEterna Zentaris's average Cyclically Adjusted Book Growth Rate was -57.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of AEterna Zentaris was 5.10% per year. The lowest was -70.40% per year. And the median was -19.70% per year.

As of today (2024-06-07), AEterna Zentaris's current stock price is €6.60. AEterna Zentaris's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €231.65. AEterna Zentaris's Cyclically Adjusted PB Ratio of today is 0.03.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AEterna Zentaris was 0.97. The lowest was 0.01. And the median was 0.06.


AEterna Zentaris Cyclically Adjusted Book per Share Historical Data

The historical data trend for AEterna Zentaris's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris Cyclically Adjusted Book per Share Chart

AEterna Zentaris Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 398.25 -301.32 276.41 489.25 300.56

AEterna Zentaris Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 584.19 523.29 379.86 300.56 231.65

Competitive Comparison of AEterna Zentaris's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, AEterna Zentaris's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AEterna Zentaris's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AEterna Zentaris's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AEterna Zentaris's Cyclically Adjusted PB Ratio falls into.



AEterna Zentaris Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AEterna Zentaris's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9.829/126.2576*126.2576
=9.829

Current CPI (Mar. 2024) = 126.2576.

AEterna Zentaris Quarterly Data

Book Value per Share CPI Adj_Book
201406 1,302.763 99.473 1,653.547
201409 877.252 99.394 1,114.347
201412 1,793.435 98.367 2,301.936
201503 2,078.587 99.789 2,629.915
201506 459.792 100.500 577.632
201509 209.960 100.421 263.978
201512 199.849 99.947 252.458
201603 147.397 101.054 184.160
201606 81.036 102.002 100.306
201609 28.968 101.765 35.940
201612 45.588 101.449 56.736
201703 36.430 102.634 44.815
201706 24.811 103.029 30.405
201709 -9.975 103.345 -12.187
201712 -14.306 103.345 -17.478
201803 57.079 105.004 68.632
201806 49.516 105.557 59.226
201809 38.623 105.636 46.163
201812 10.194 105.399 12.211
201903 -19.166 106.979 -22.620
201906 -16.114 107.690 -18.892
201909 -9.958 107.611 -11.683
201912 -11.088 107.769 -12.990
202003 6.505 107.927 7.610
202006 3.507 108.401 4.085
202009 20.519 108.164 23.951
202012 17.325 108.559 20.149
202103 44.494 110.298 50.932
202106 41.978 111.720 47.440
202109 41.959 112.905 46.921
202112 38.628 113.774 42.866
202203 39.760 117.646 42.671
202206 42.309 120.806 44.218
202209 41.115 120.648 43.027
202212 27.820 120.964 29.037
202303 24.010 122.702 24.706
202306 22.109 124.203 22.475
202309 20.282 125.230 20.448
202312 13.745 125.072 13.875
202403 9.829 126.258 9.829

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


AEterna Zentaris  (STU:ET80) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AEterna Zentaris's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=6.60/231.65
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AEterna Zentaris was 0.97. The lowest was 0.01. And the median was 0.06.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


AEterna Zentaris Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


AEterna Zentaris (STU:ET80) Business Description

Industry
Traded in Other Exchanges
Address
222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.

AEterna Zentaris (STU:ET80) Headlines

No Headlines